4Scaill-L,Carrol-D,Burke-K.Methyl- phenidate mechanism of action and clinical update[J].J-Child-Adolesc- Psychiatr-Nars,2004,17(2):85 - 86.
5Americal Academy of Child and Adolescent Psychiatry official Action.Practice parameter for the use of stimiulant madications in the treatment of children,adolescents andadults[J].J Am Acad Child Adolesc Psychiatry,2002,42(Suppl 2):26s-49s.
7Americal Academy of Pediatrices. Clinical practice guideline:treatment of the school-aged child with attention deficit hyperactive disorder[J]. Pediatrice,2001,108:1033-1044.
8Klein RC.Clinical efficacy of methylphenidate in childred and adolescents[J].Encephale,1993,19:89-93.
9Kramer JR,Loney J,Ponto LB,et al. Predicitors of adult height and weight in boys treated with methylphenidate for childhood behavior problem[J]. J Am Acad Child Adolesc Psychiatry,2000,39:517 - 524.
10Wilens TE.ADHD treatment with a once- daily formulation of methylphenidate hydrochloride a two-year study[J].Phila- delphia: PA,2002-18- 23.
3DALY G, HAWI Z, FITZGERALD M, et al. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children[J]. Mol Psychiatry, 1999,4:192-196.
4COOK EH, STEIN MA, KRASOWSKI MD, et al. Association of attention-deficit disorder and dopamine transporter gene[J]. Am J Hum Genet, 1995,56: 993-998.
5FARAONE SV, BIEDERMAN J, MONUTEAUX MC. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder [J]. Genet Epidemiol, 2000, 18: 1-16.
6KANG AM, PALMATIERMA, KIDDKK. Global variation of a 40-bp VNTR in the 3 '-untranslated region of the dopamine transporter gene (SLC6A3) [J]. Biol Psychiatry, 1999, 46 (2):151-160.
7TAO LI, LIU YANG, CLAUDIA WIESE, et al . No association between alleles or genotypes at the dopamine transporter gene and schizophrenia[J]. Psychiatry Search, 1994,52(1): 17-19.
8BARR CL, XU C, KROFT J, et al. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder [J]. Biol Psychiatry,2001,49(4) :333-339.
